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Gene regulationOdorant receptor (OR) genes constitute with 1200 members the largest gene family in the mouse genome. A
mature olfactory sensory neuron (OSN) is thought to express just one OR gene, and from one allele. The cell
bodies of OSNs that express a given OR gene display a mosaic pattern within a particular region of the main
olfactory epithelium. The mechanisms and cis-acting DNA elements that regulate the expression of one OR
gene per OSN — OR gene choice — remain poorly understood. Here, we describe a reporter assay to identify
minimal promoters for OR genes in transgenic mice, which are produced by the conventional method of
pronuclear injection of DNA. The promoter transgenes are devoid of an OR coding sequence, and instead drive
expression of the axonal marker tau-β-galactosidase. For four mouse OR genes (M71, M72, MOR23, and P3)
and one human OR gene (hM72), a mosaic, OSN-speciﬁc pattern of reporter expression can be obtained in
transgenic mice with contiguous DNA segments of only ~300 bp that are centered around the transcription
start site (TSS). The ~150 bp region upstream of the TSS contains three conserved sequence motifs, including
homeodomain (HD) binding sites. Such HD binding sites are also present in the H and P elements, DNA
sequences that are known to strongly inﬂuence OR gene expression. When a 19mer encompassing a HD
binding site from the P element is multimerized nine times and added upstream of a MOR23 minigene that
contains the MOR23 coding region, we observe a dramatic increase in the number of transgene-expressing
founders and lines and in the number of labeled OSNs. By contrast, a nine times multimerized 19mer with a
mutant HD binding site does not have these effects. We hypothesize that HD binding sites in the H and P
elements and in OR promoters modulate the probability of OR gene choice.ysics, Max-von-Laue-Strasse 3,
P. Mombaerts).
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The mouse olfactory system relies on ~1200 distinct types of ORs
to detect chemical information in the external environment (Buck and
Axel, 1991). Odorous ligands bind to ORs on cilia of OSNs within the
main olfactory epithelium (MOE) that lines the nasal cavity.
Individual OSNs are thought to express only a single OR gene (Malnic
et al., 1999), and express one allele of a given OR gene (Chess et al.,
1994; Strotmann et al., 2000). Due to the size of the OR repertoire and
to monogenic expression, the population of OSNs that express a given
OR is relatively small, with the numbers varying over two orders of
magnitude (Mombaerts, 2004). A given OR gene is expressed in a
mosaic or punctate pattern in the mouse, within a characteristicregion (typically referred to as zone) of the MOE (Ressler et al. 1993;
Miyamichi et al., 2005). Axons of OSNs that express a given OR gene
coalesce into one or a few glomeruli in each of the two halves of the
two olfactory bulb in themouse (Ressler et al., 1994; Mombaerts et al.,
1996). OR gene expression is thus characterized by at least ﬁve
features: monogenic expression on a per OSN basis, monoallelic
expression on a per OSN basis, mosaic or punctate expression in the
MOE, expression within a characteristic region of the MOE, and
coalescence of OSN axons into glomeruli. These expression features
are commonly referred to as OR gene choice.
As a ﬁrst approach to understand the mechanisms and cis-acting
DNA elements of OR gene choice, we and others have used transgenic
mouse technology, in order to identify DNA segments of OR loci that
reproduce some or all of these ﬁve features when inserted ectopically
in the mouse genome (Bozza et al., 2009; Oka et al., 2006; Qasba and
Reed, 1998; Rothman et al., 2005; Serizawa et al., 2000, 2003; Vassalli
et al., 2002; Zhang et al., 2007). Our ~9 kilobase (kb) transgenes for
M71 and MOR23 (Rothman et al., 2005; Vassalli et al., 2002) and the
10.5 kb transgene forMOR262-12 (Zhang et al., 2007) are the smallest
transgenes that provide the best reproduction of the ﬁve features of
the endogenous OR genes. Most importantly, axons of transgene-he probability of odorant receptor gene choice in
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sponding endogenous OR locus to same glomeruli. These small
transgenes, which contain the OR coding sequence, are typically
referred to as minigenes.
TheM71 andMOR23minigenes (Rothman et al., 2005; Vassalli et al.,
2002) consist of four segments from the OR locus: a nontranscribed
region upstream of the TSS; one or two 5′ nontranslated exons; the OR
coding sequence (which has no introns); and a 3′ nontranslated region.
Deletion of both introns of MOR23 still permits transgene expression:
Tg3′Δ with 2.2 kb of genomic DNA (Vassalli et al., 2002). MOR23
minigene expression requires a 405 bp region upstream of the TSS,
which consists of a 257 bp fragment of a LINE-1 repetitive DNA element
followed by 148 bp of unique sequence (Vassalli et al., 2002). For the
M71 minigene, a 161 bp region upstream of the TSS is required for
transgene expression: Tg(161) with 7.1 kb of genomic DNA (Rothman
et al., 2005). TheMOR262-12minigene contains 358 bp upstreamof the
TSS (Zhang et al., 2007).
Conserved sequence motifs reside within these promoter regions
(Rothman et al., 2005; Vassalli et al., 2002; Zhang et al., 2007). Two of
these motifs lie in close proximity of each other: a putative homeo-
domain (HD) binding site and an OLF/EBP (O/E)-binding site. By site-
directed mutagenesis of the M71 minigene and of the corresponding
sequences in the endogenousM71 locus using gene targeting, we have
demonstrated that these HD and O/E motifs are involved in transgene
and endogenous OR gene expression, respectively (Rothman et al.,
2005). We identiﬁed the LIM-homeodomain protein LHX2 using the
HD binding site in the M71 promoter as bait (Hirota and Mombaerts,
2004). We found that Lhx2 is required for class II OR but not for class I
OR gene expression and/or for maturation of the OSNs that express
class II OR genes (Hirota and Mombaerts, 2004; Hirota et al., 2007).
Classical strategies of promoter mapping are performed in cell
lines or in vivowith constructs in which short upstream genomic DNA
segments are fused to a sequence encoding a reporter such as GFP or
lacZ. All but the ﬁrst (Qasba and Reed, 1998) transgenic OR constructs
include the OR coding sequence and some surrounding sequences,
because of the well-established role of the OR in coalescence of axons
into glomeruli (Mombaerts et al., 1996; Mombaerts, 2006). Co-
convergence of axons of transgene-expressing OSNs to the same
glomeruli as axons of OSNs expressing the corresponding endogenous
OR is the best criterion to assess the ﬁdelity of the expression patterns.
However, there is some evidence that the OR coding sequence itself is
somehow involved in the regulation of OR gene expression (Nguyen
et al., 2007). To dissect further the sequences with promoter activity
in transgenic mice, there is thus a need for a reduced reporter assay
that is devoid of OR coding sequence.
Here, we have developed such a transgenic reporter assay. We
have used it to deﬁne minimal OR promoters for mouse and human
OR genes in transgenic mice, which are produced conventionally by
pronuclear injection of DNA. These promoter transgenes drive
expression of the axonal maker tau-β-galactosidase. The transgenic
OR promoters are ~300 bp contiguous segments centered around the
TSS as deﬁned by 5′RACE, or around the predicted TSS for the human
OR gene as deﬁned by sequence homology. We show that mutations
in the HD and O/E binding sites abolish transgene expression of a
337 bp minimal promoter forM71. A segment of 317 bp that has high
sequence identity to the P3 minimal promoter but could not be linked
to transcripts containing an OR coding sequence, confers unexpected
expression in up to 10% of OSNs, and has been termed the P element
(Bozza et al., 2009). The ~150 bp regions upstream of these TSSs
contain conserved motifs of HD and O/E binding sites, and another
motif just upstream of the TSS. A similar arrangement of motifs is
found in a central region of the 2.1 kb H element (Serizawa et al.,
2003; Nishizumi et al., 2007). We further concentrated on a 13 bp
perfect match containing a HD binding site that is shared among the
P3 minimal promoter, the H and the P elements. When a 19 bp
sequence from the P element that encompasses this 13 bp sequence isPlease cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11multimerized nine times and inserted upstream of aMOR23minigene
(which contains the MOR23 coding sequence), most transgenic
founders and lines express the transgene, and many lines display a
dramatic increase in the number of labeled OSNs. By contrast, a nine
times-multimerized 19 bp sequence with a mutant HD binding site
does not have these effects on the number of transgene-expressing
founders and lines, and on the number of labeled OSNs; it is
essentially neutral with regard to transgene expression.
We hypothesize that these HD binding sites modulate the
probability of OR gene choice: the frequency with which a given OR
gene is chosen for expression by an OSNwithin a characteristic region
of the MOE.
Results
Transgenic promoters of ~300 bp contiguous segments
In our novel transgenic assay for OR promoter activity, there is no
heterologous DNA sequence to provide basal promoter activity, and
no OR coding sequence. The segments fromOR loci are contiguous and
~300 bp in length. These segments consist of ~150 bp upstream of the
TSS followed by ~150 bp downstream; the downstream segment
corresponds, generally, to the ﬁrst nontranslated exon. These
segments are tested in the context of a downstream tauLacZ reporter
sequence, which is followed by a rabbit β-globin polyadenylation
signal (-LacZpA). We term these transgenes Tg-OR(x,y)-LacZpA, with
OR the locus, and x and y the length in bp of sequence that is upstream
and downstream, respectively, of the TSS as deﬁned by 5′RACE.
In minigenes (Oka et al., 2006; Rothman et al., 2005; Vassalli et al.,
2002; Zhang et al., 2007), the presence of an intact OR coding
sequence enables monogenic expression and coalescence of labeled
axons into glomeruli (Figs. 1A, D). By contrast, in our reduced reporter
assay, the promoter transgenes do not contain an OR coding sequence.
We ﬁnd that labeled axons project diffusely to a broad domain of the
OB (Figs. 1B, E, 2), instead of coalescing into one or a few glomeruli per
half-OB, as is the case with minigenes (Figs. 1A, D). This phenotype of
diffuse axonal projections is commonly observed with other trans-
genes (small or large) that lack a functional OR coding sequence
(Serizawa et al., 2003) and with gene-targeted mutations that delete
or otherwise cripple the OR coding sequence (Bozza et al., 2009;
Feinstein et al., 2004; Grosmaitre et al., 2009; Lewcock and Reed,
2004; Shykind et al., 2004).
We have here studied four mouse OR genes and one human OR
gene (Figs. 1–3).
Mouse M71
We have previously shown that a minigene with 9.2 kb of M71
genomic DNA confers tau-β-galactosidase expression to OSNs within
a dorsal region of the MOE, and enables axonal coalescence into
glomeruli that reside within the dorsal–caudal OB (Vassalli et al.,
2002). The genomic sequences in this Tg-M71-LacZ minigene, which
was abbreviated as M71-TgA in Vassalli et al., 2002, consist of 2.3 kb
upstream of the TSS, followed by the nontranslated exon, the 2.0 kb
intron, and the coding exon of M71, with 3.8 kb downstream of the
M71 stop codon. The IRES-taulacZ sequence was inserted between the
M71 stop codon and the 3.8 kb downstream segment (Fig. 1A).
We have now dissected theM71 promoter further in our promoter
transgene assay. We used a 337 bp segment of the M71 locus that
consists of the same 161 bp upstream of the TSS as in Tg (161)
(Rothman et al., 2005), followed by the entire 5′ nontranslated exon
(176 bp), constructing promoter transgene Tg-M71(161,176)-LacZpA
(Fig. 1B). Of four transgenic founders, three display mosaic β-
galactosidase expression in the dorsal MOE (Figs. 1B, 3), similar to
theM71minigene (Fig. 1A). By breeding three additional founders, we
established three independent mouse lines carrying this transgene.otifs modulate the probability of odorant receptor gene choice in
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Fig. 1.Minimal M71 andMOR23 promoter transgenes derived from OR minigenes. Left, design of the transgenes. Right, X-gal stained wholemounts from a right half-head, view on
the medial aspect; anterior is to the left, dorsal is to the top. (A) Minigene Tg-M71-LacZ (Vassalli et al., 2002). After the stop codon of the M71 coding sequence (yellow box) is
inserted an IRES (grey box) and the tauLacZ sequence (blue box). This transgene contains a total of 9.2 kb from theM71 locus: 2.3 kb upstream of the TSS, the 5′ nontranslated exon
(short white box), the 2.0 kb intron, the 930 bp M71 coding sequence, and 3.8 kb downstream of the stop codon. Hooked arrow indicates TSS and direction of transcription. The
wholemount is from amouse of line M71-TgA described in Vassalli et al., 2002. X-gal labeled cells reside in the dorsal region of theMOE, and their axons coalesce into one glomerulus
in the medial half-bulb. (B) Promoter transgene Tg-M71(161,176)-LacZpA. A 337 bp contiguous fragment from the M71 locus centered around the TSS of M71 is placed 5′ to the
tauLacZ sequence (blue box), which is followed by the rabbit globin polyadenylation sequence (thin white box). The 337 bp fragment represents 161 bp (black box) upstream of the
TSS and 176 bp (thick white box) ofM71 non-coding exon 1. This transgene does not contain an OR coding sequence. A transgenic founder shows X-gal labeled cells predominantly
in the dorsal region of the MOE. In contrast to (A), labeled axons do not coalesce into glomeruli, but spread over a large domain in the dorsal aspect of the medial half-bulb.
(C) Promoter transgene Tg-M71(161mHD+O/E,176)-LacZpA. Within the same 337 bp segment from the M71 locus as in (B), two conserved motifs, the homeodomain (HD) and
OLF/EBP (O/E) binding sites have been mutated from TAATTG to TGGTTG and from ATCCCAGGAGAT to ATAGGAGGAGAT, respectively. These mutations are within the 161 bp segment
(thin red box) upstream of the TSS. A transgenic founder shows a very few X-gal labeled cells in the MOE. No labeled axons are observed on the olfactory bulb. (D) Minigene Tg-
MOR23-LacZ (Vassalli et al., 2002). After the stop codon of the MOR23 coding sequence (orange box) is inserted an IRES (grey box) and the taulacZ sequence (dark blue box). This
transgene contains a total of 9.4 kb from theMOR23 locus: 405 bp upstream of the TSS, two 5′ untranslated exons (short white boxes), the 930 bpMOR23 coding sequence, and 1.7 kb
downstream of the stop codon. Hooked arrow indicates TSS and direction of transcription. The wholemount is from a mouse of line TgSN-2 described in Vassalli et al., 2002. X-gal
labeled cells are found in the dorsal region of the MOE, and their axons coalesce into one glomerulus in the medial half-bulb. (E) Promoter transgene Tg-MOR23(148,154)-LacZpA. A
302 bp contiguous fragment of the MOR23 locus centered around the TSS of MOR23 is placed 5′ to the tauLacZ sequence (blue box), which is followed by the rabbit globin
polyadenylation sequence (thin white box). The 302 bp fragment represents 148 bp TSS (black box) upstream of the TSS and 154 bp of nontranslated exon 1 (thick white box). This
transgene does not contain an OR coding sequence. The wholemount is from amouse of line I. X-gal labeled cells reside predominantly in the dorsal region of the MOE. In contrast to
(D), labeled axons do not coalesce into glomeruli, but project diffusely to a large subdomain centrally in the medial half-bulb.
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Fig. 2. Additional promoter transgenes. (A) Promoter transgene Tg-M71(161,176)-LacZpA. Wholemount from a mouse of line I. See also Fig. 1B. (B) Promoter transgene Tg-hM72
(154,146)-LacZpA. A 300 bp contiguous fragment from a human OR locus deﬁned by homology to the M71 and M72 promoters, is placed 5′ to the tauLacZpA reporter. The 300 bp is
presumed to represent 154 bp upstream of the hypothetical human TSS and 146 bp of a hypothetical nontranslated exon 1 (a putative splice donor site is observed following the 146 bp
sequence). This transgene does not contain an OR coding sequence.Wholemount from amouse of line IV. X-gal labeled cells reside predominantly in a ventral region of theMOE. Labeled
axons project diffusely to a large subdomain of themedial half-OB. (C) Promoter transgene Tg-P3(143,163)-LacZpA. A 306 bp contiguous fragment from the P3 locus centered around the
TSS of P3 is placed 5′ to the tauLacZpA reporter. The 306 bp fragment represents 143 bp upstream of the putative TSS and 163 bp of P3 nontranslated exon 1 (Lane et al., 2001). This
transgene does not contain an OR coding sequence. Wholemount from a mouse of line IV. X-gal labeled cells reside predominantly in a ventral region of the MOE. Labeled axons project
diffusely to a large subdomain in the ventral,medial half-OB. (D) Transgene Tg-P(122,195)-LacZpA. A 317 bp fragment (the P element) deﬁned byhomology to theminimal P3promoter is
placed5′ to the tauLacZpAreporter. This transgenedoesnot contain anORcoding sequence.Wholemount fromamouseofP-LacZ-Tg line8 (Bozza et al., 2009).X-gal labeledneurons reside
throughout the entire MOE. Labeled axons project diffusely to the majority of the surface of the medial half-OB except for a dorsal, wedge-shaped domain.
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similar numbers of labeled OSNs as the gene-targeted strain M71-
IRES-taulacZ (Fig. 3).
This 161 bp upstream sequence contains one HD and one O/E
binding site (Rothman et al., 2005). We have previously shown that
mutations of both the HD and O/E sites within a minigene that
contains a slightly longer upstream sequence, Tg(491, Hom+O/E),
result in nearly no transgene expression (Rothman et al., 2005). To
test the relevance of these sites in the expression of promoter
transgenes, the same ﬁve nucleotide substitutions as in minigene Tg
(491, Hom+O/E) were introduced in order to convert the HD
binding site TAATTG into TGGTTG and the O/E binding site
ATCCCAGGAGAT into ATAGGAGGAGAT, constructing promoter trans-
gene Tg-M71(161mHD+O/E, 176)-LacZpA (Fig. 1C). These muta-
tions are known to interfere with the binding of HD and O/E
proteins, respectively, to these DNA sequences. We ﬁnd that these
ﬁve substitutions also result in no transgene expression in 2/6
founders and low transgene expression in the other four founders
(Fig. 3). No mouse strains were established. Thus, our transgenic
reporter assay, which does not include the OR coding sequence and
intronic sequences, conﬁrms the relevance of the HD and O/E
binding sites in the 161 bp region upstream of the TSS.
To determinewhether the TSSs in theM71 promoter transgene are
the same as in the endogenous M71 gene, we performed 5′ RACE on
RNA from olfactory mucosa of transgenic mice. Two independent Tg-
M71(161, 176)-LacZpA lines (lines I and IV) reveal TSSs at the exact
same nucleotide (data not shown) as the endogenous M71 genePlease cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11(Rothman et al., 2005). The promoter transgenes are thus not
expressed from alternate promoters in the genome.
Mouse MOR23
We have previously described aMOR23minigene of 9.4 kb genomic
DNA, with 405 bp upstream sequence and two 5′ nontranslated exons
(Vassalli et al., 2002). An example of amouse carrying thisminigene Tg-
MOR23-LacZ (line TgSN-2 in Vassalli et al., 2002) is shown in Fig. 1D. By
fusing the two nontranslated exons directly with the MOR23 coding
sequence, we have shown that the introns are not necessary for
transgene expression (TgΔΔ and Tg3’Δ Vassalli et al., 2002).
We have now further dissected theMOR23 promoter in our promoter
transgene assay. We used a 302 bp segment of the MOR23 locus that
consists of 148 bp upstream of the TSS (which represents all unique
sequences of the 405 bp upstream sequence of Tg-MOR23-LacZ) and the
entire5′nontranslatedexon1ofMOR23 (154 bp), constructingpromoter
transgeneTg-MOR23(148,154)-LacZpA(Fig. 1E). Of four transgenic lines,
two express β-galactosidase activity in a mosaic OSN-speciﬁc pattern
(Fig. 1E). At four weeks of age, the distribution in theMOE is very similar
to that of TgSN-2 mice, but there are a few X-gal stained cells that are
more ventral (Fig. 1D). At postnatal day 8, the expression domain in both
Tg-MOR23(148,154)-LacZpA lines is broader and extends ventrally (data
not shown). We have also observed labeled cells in the ventral MOE of
young mice of the gene-targeted MOR23-IRES-tauGFP strain, suggesting
that these ectopic cells exist naturally but do not persist, presumably
during a process of reﬁnement (Vassalli et al., 2002).otifs modulate the probability of odorant receptor gene choice in
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Fig. 3. Cell counts for the various promoter transgenes. Eight minimal OR promoters and the P element were tested for expression in our transgenic assay using the tauLacZ reporter
and the rabbit globin polyadenylation sequence. None of these transgenes contains an OR coding sequence. Nomenclature of promoter fragments is OR(X,Y) with OR representing
the name of the OR gene, X representing the sequence upstream of the TSS and Y the sequence downstream of the TSS. The mHD+O/E mutation in the M71 promoter is indicated
with an asterisk after 161. Counts of X-gal labeled cells on the medial aspect of olfactory turbinates in wholemounts (in ranges of 10 s) are from transgenic founders (circles) and
from lines (squares). Cell counts from lines are from at least three mice, which are hemi- or homozygous for the transgene. For reference, labeled cells were counted for at least three
heterozygous mice (stars) of the corresponding lines with gene-targeted IRES-taulacZ insertions: MOR23, M71, M72, and P3.
5A. Vassalli et al. / Molecular and Cellular Neuroscience xxx (2010) xxx–xxxWe truncated theMOR23 promoter from 154 to 40 bp downstream
of the TSS, thereby deleting one of the two conserved O/E sites in exon
1, constructing promoter transgene Tg-MOR23(148,40)-LacZpA
(Fig. 3). Among three transgenic lines, one does not express and
two show a very few labeled neurons in the MOE, with an extended,
ventralized distribution (data not shown). Although the number of
lines is limited, the effect of this truncation suggests a role for the
second O/E binding site in the ﬁrst MOR23 nontranslated exon.
Mouse M72
The M72 OR gene is very similar to the M71 OR gene: it is also
expressed in the dorsal MOE, it has a single 5′ nontranslated exon,
96% bp identity in the OR coding sequence, and high sequence
identity in the promoter region (Vassalli et al., 2002). M71 and M72Please cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11share three strikingly conserved motifs in the promoter region: two
HDbinding sites, oneO/E binding site, and a thirdmotif just upstream
of the TSS (Vassalli et al., 2002; Fig. 5). No M72 minigenes have been
reported.
We asked whether the M71-homologous region upstream of the
M72 TSS (135 bp) plus the ﬁrst nontranslated exon of M72 (163 bp)
would be sufﬁcient for transgene expression, constructing promoter
transgene Tg-M72(135,163)-LacZpA. We obtained an unusually high
efﬁciency of transgene integration, and generated 17 founders. We
ﬁnd that 5/5 founders and 9/12 mouse lines show mosaic β-
galactosidase expression in the MOE (Fig. 3). Expression is ventralized
relative to the normal pattern however (data not shown). Thus, our
novel assay demonstrates that a ~300 bp region centered around the
TSS generates M72-like promoter activity in a promoter transgene,
without having characterized previously M72 minigenes.otifs modulate the probability of odorant receptor gene choice in
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The human genome harbors on Chromosome 11 an OR gene that is
orthologous to both the mouse M71 and M72 OR genes: OR8A1. We
term this gene hM72, with ‘h’ for ‘human’. The putative upstream
region of hM72 also contains the conserved HD and O/E binding
sites and a predicted TSS (Fig. 5). In view of our success with the
M71 and M72 promoter transgenes, we tested the function of the
predicted hM72 promoter in transgenic mice, constructing promoter
transgene Tg-hM72(154,146)-LacZpA. Of three lines, two reveal
mosaic expression in the MOE. The most robustly expressing line
shows β-galactosidase-positive OSNs distributed across the entire
MOE except for themost ventral aspect (Fig. 2B).We then constructed
promoter transgene Tg-hM72(110,29)-LacZpA, in which the 5′ end is
truncated by 44 bp (leaving the three conservedmotifs intact) and the
3′ end of the ﬁrst nontranslated exon is truncated by 117 bp. None of
three transgenic lines show expression (Fig. 3). To our knowledge,
hM72(154,146)-LacZpA deﬁnes the ﬁrst promoter region for a human
OR gene experimentally in mice.
Mouse P3
The mouse MOR23, M71 and M72 OR genes are expressed in the
dorsal MOE. To extend our analysis of OR promoters to an OR gene
that is expressed in the ventral MOE, we chose the OR gene P3, for
which we have reported the gene-targeted strains P3-IRES-tauGFP
and P3-IRES-taulacZ (Feinstein and Mombaerts, 2004). The complete
exon–intron structure of P3 is known (Lane et al., 2001). We tested a
segment of 306 bp that consists of 143 bp upstream of the TSS and a
portion of the ﬁrst non-coding exon (163 bp): promoter transgene Tg-
P3(143,163)-LacZpA. The 143 bp upstream region contains a variant
HDmotif and an O/E site in close proximity (Fig. 5). All ﬁve transgenic
lines showmosaic β-galactosidase expressionwithin the ventral MOE,
similar in region and in numbers to P3-IRES-tauLacZ (Figs. 2C, 3).
Thus, short and proximal promoters are not limited to OR genes
with expression in the dorsal MOE.
The P element
Unlike the P3OR gene, the exon–intron structure of the P4OR gene
has not been reported. We performed 5′ RACE analysis for P4 and
identiﬁed a potential TSS site. Because the upstream region reveals no
conserved motifs and no homology with the 306 bp P3 promoter
sequence, no promoter transgene was constructed for P4.
Interestingly, alignment of the 306 bp P3 promoter sequence with
the genomic region between the P3 and P4 coding sequences reveals a
stretch of striking homology (Lane et al., 2001; Bozza et al., 2009;
Fig. 5). This homology region is located 22.1 kb upstream of the
putative P4 TSS. We reasoned that this homology region may
represent an additional or cryptic TSS for the P4 OR gene, although
we were unable to link it by RT-PCR with the P4 coding sequence.
Close comparison between this homology region and the 306 bp P3
promoter sequence reveals a 317 bp equivalent segment, with a set of
common HD and O/E binding sites. We have termed this 317 bp
sequence the ‘P element’ (Bozza et al., 2009). Promoter transgene Tg-P
(122,195)-LacZpA (referred to as P-Tg-LacZ in Bozza et al., 2009) was
generated according to the same design principles as for the promoter
transgenes described above.
Among 11 lines, eight show mosaic expression of β-galactosidase
in the MOE (Figs. 2, 3). Remarkably, of these eight lines, in four the
numbers of labeled cells are dramatically higher than in all the other
promoter transgenes described above — as high as 10% of all cells in
the MOE. This unusually high cell number can be seen both with a
single-copy integration transgene (line 8, Fig. 2D) and with a
multicopy integration transgene (line 11, data not shown). To date
there is no explanation for this high frequency of expression of the PPlease cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11element across OSNs. We have demonstrated (Bozza et al., 2009) that
promoter transgene Tg-P(122,195)-LacZpA can serve as a marker for
the population of OSNs that express class II (but not class I) OR genes.
MOE expression patterns and axonal projections
MOR23 andM71minigenes reproduce closely the expressionpatterns
in the dorsal MOE (Vassalli et al., 2002; Rothman et al., 2005). The novel
MOR23 andM71 promoter transgenes generate β-galactosidase expres-
sion in patterns that are similar to the corresponding minigenes, but
some additional expression in the ventral MOE is observed. When Tg-
MOR23(148,154)-LacZpA mice are crossed to gene-targeted MOR23-
IRES-tauGFPmice,we observe overlapping patterns of labeled cells in the
MOE; curiously, labeled cells often come in pairs (Figs. 4A, B). The
expression pattern of Tg-P3(143,163)-LacZpA is also shifted slightly
ventrally relative to P3-IRES-tauLacZ mice (Fig. 2C). In a cross to gene-
targeted P3-IRES-tauGFP mice, the patterns of labeled cells in the MOE
overlap (Fig. 4D). Thus, the promoter transgenes produce patterns that
are very similar but not identical in all their details to the endogenous
counterparts.
Contrary to the minigenes, the promoter transgenes do not
express an OR protein from the transgene. Their axons are thus not
expected to coalesce into one or a few glomeruli per half-OB. In
wholemounts, we observe that labeled axons project diffusely to a
broad subdomain of the OB in all lines (Figs. 1B, E, 2). In histological
sections, axons enter or pass through glomeruli. Some labeled axons
of Tg-MOR23(148,154)-LacZpA mice enter or pass through the
endogenousMOR23 glomeruli; axons that synapse in these glomeruli,
would reﬂect the occasional co-expression of the promoter transgene
with the endogenous MOR23 gene (Figs. 4C, C’). Some labeled axons
of Tg-P3(143,163)-LacZpA mice enter or pass through glomeruli that
are adjacent to the endogenous P3 glomeruli (Fig. 4E). In striking
contrast, labeled axons of Tg-P(122,195)-LacZpA mice project, in
varying extents, to numerous glomeruli across the OB except for the
most dorsal part (Fig. 4F).
In conclusion, the diffuseness of the OSN axonal projections in the
promoter transgenes is consistent with patterns reported for
transgenic or gene-targeted mice in which an OR coding sequence is
deleted and replacedwith amarker (Bozza et al., 2009; Feinstein et al.,
2004; Grosmaitre et al., 2009; Lewcock and Reed, 2004; Serizawa et
al., 2003; Shykind et al., 2004). The fraction of the promoter
transgene-expressing OSNs that coexpress an OR from an endogenous
locus remains to be determined.
Sequence homology between minimal OR promoters and the H and P
elements
Alignment of the ~150 bp sequence upstream of the TSS of M71,
M72, and hM72 reveals three highly conserved motifs (Fig. 5A, top): a
HD binding site (TAATN5N6), an O/E binding site (YYYCARRRR), and a
third conserved sequence (AAACAG/CA; Vassalli et al., 2002) near the
TSS. The latter sequence is identical to an H1-box variant upstream of
the Histone H1 gene (Eilers et al., 1994). A second conserved HD
binding site is at the 5′ end of the promoter regions, but in the
antiparallel orientation (Fig. 5A, top). These motifs are also found in a
similar relative arrangement when the 143 bp sequence upstream of
the TSS of mouse P3 and the corresponding 122 bp sequence of the P
element in mouse are compared (Fig. 5A, middle).
The P3 minimal promoter and the P element share sequence
motifs, but produce vastly different numbers of transgene-expressing
OSNs. The high number of OSNs expressing the P transgene is
reminiscent of the high numbers of MOR28-expressing OSNs when
the H element (2125 bp) is placed upstream of a MOR28 minigene
(Serizawa et al., 2003). We reasoned that there may be sequences
common to the H element and our 317 bp P element. Indeed, a scan of
the H element sequence reveals several striking similarities in theotifs modulate the probability of odorant receptor gene choice in
.001
Fig. 4. Promoter transgene expression in the MOE and axonal projections. (A) Section through the dorsal aspect of the MOE from a Tg-MOR23(148,154)-LacZpA mouse (line I)
crossed with MOR23-IRES-tauGFP. OSNs that express the promoter transgene are red-ﬂuorescent (anti-β-galactosidase), and OSNs that express the endogenous MOR23 locus are
green-ﬂuorescent (GFP). Nuclei are labeled blue. Red- and green-ﬂuorescent OSNs are often in close proximity to each other (arrows). (B) Higher magniﬁcation of the box in (A).
(C) Section through the OB of a Tg-MOR23(148,154)-LacZpA mouse (line I) crossed with MOR23-IRES-tauGFP. Glomeruli are outlined in blue by the nuclei of periglomerular cells.
Red-ﬂuorescent axons, which are from OSNs expressing the transgene, enter or pass through numerous glomeruli, including an endogenous MOR23 glomerulus (arrow). (C’) Same
section as (C). Green-ﬂuorescent axons, which are from OSNs expressing the endogenousMOR23 locus, coalesce into a glomerulus. Arrow indicates red-ﬂuorescent axons that either
enter or pass through the MOR23 glomerulus. (D) Section through the ventral aspect of the MOE from a Tg-P3(143,163)-LacZpA mouse (line IV) crossed with P3-IRES-tauGFP. OSNs
that express the transgene are red-ﬂuorescent (anti-β-galactosidase), and OSNs that express the endogenous P3 locus are green-ﬂuorescent (GFP). Nuclei are labeled blue.
(E) Section through the olfactory bulb of a Tg-P3(143,163)-LacZpA mouse (line IV) crossed with P3-IRES-tauGFP. Glomeruli are outlined in blue by the nuclei of periglomerular cells.
A red-ﬂuorescent axon or axon bundle (anti-β-galactosidase) enters a glomerulus next to an endogenous P3 glomerulus, which is green-ﬂuorescent. (F) Section through the medial
portion of both bulbs from a Tg-P4(122, 195)-LacZpA mouse (line 8, Bozza et al., 2009). Glomeruli are outlined in blue by the nuclei of periglomerular cells. Red-ﬂuorescent axons
(anti-β-galactosidase) innervate many glomeruli, and to various extents.
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Fig. 5. Conserved sequence motifs in minimal OR promoters and the H and P elements. (A) (Top) Comparison of the sequences upstream of the TSS of mouse M71 (161 bp), mouse
M72 (135 bp) and human hM72 (154 bp) reveals four stretches of homology, which are indicated with colored, shaded boxes: two potential homeodomain (HD) binding sites (red
boxes), one O/E binding site (purple box) and one site (blue box) of unknown function near the TSS. The green, non-shaded box depicts a stretch of additional sequence homology
downstream of the ﬁrst HD binding site (which is on the opposite strand) forM71,M72 and hM72. The symbol + denotes identity among the three sequences. (Middle) Comparison
of the sequences upstream of the TSS of P3 (143 bp) and the corresponding site in the P element (122 bp) reveals ﬁve stretches of homology: three HD binding sites (red boxes), one
O/E binding site (purple box) and the same site (blue box) of unknown function near the TSS. Sequence comparison among all ﬁve sequences is shown between the top and middle:
it reveals the strongest homology in HD sites, O/E sites, and the AAACAG/CA site near the TSS. The symbol + denotes identity among the ﬁve sequences. Y is T or C, and R is A or G.
(Bottom) Results from sequence analysis are schematized to show orientation of conserved sequences. HD sites are numbered. For reference, asterisks represent conserved
sequences in M71, M72 and hM72 that we reported previously (Vassalli et al., 2002). The orientation of the motifs on either DNA strand is represented with arrows in different
directions and with ﬁlled or unﬁlled arrowheads. (B) Sequence analysis of a central 158 bp region within the 2125 bp H element. Hf denotes a forward orientation with regard to the
MOR28 promoter in endogenous locus. The central 158 bp region is of interest, as it contains two O/E sites (purple arrows) and four HD sites (red arrows) in close proximity. These
HD sites are identical to those in the core-H region described in Nishizumi et al., 2007. (C) Sequences of HD binding sites in the various promoter segments and the H and P elements.
The H and P elements have three HD binding sites of the TAATGA type, and the P3 promoter has two such sites. Core HD sequence TAAT is indicated in brown. A 19mer sequence from
the P element encompassing the 13mer AACTTTTTAATGA that is shared with the H element and the P3 promoter, is multimerized nine times in the 9x19HD experiments.
8 A. Vassalli et al. / Molecular and Cellular Neuroscience xxx (2010) xxx–xxxnumber, orientation and types of HD binding sites along with
neighboring O/E binding sites, particularly in a central 158 bp region
(Figs. 5B, C).
Wehypothesize that theprecise sequenceof theHDbindingsitemay
modulate the probability of gene expression. The HD binding sites in
M71,M72 and hM72 all contain the TAATT pentamer sequence, but have
variability at N6. The P3 promoter and the P element contain the TAATG
pentamer sequence,with P3 showing variability in one of itsHDbinding
sites at N6 (Fig. 5C). Comparison between the HD binding sites in the P
element and in a central 158 bp region of theH element, which overlaps
with the core-H region (Nishizumi et al., 2007), reveals three
occurrences of TAATGA in common and an extended 13 bp perfectPlease cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11match (AACTTTTTAATGA) at one of these HD binding sites (Fig. 5C). This
13 bp sequence also occurs in the P3 promoter.
Thus, the M71, M72, hM72, and P3 promoters and the P element
share homologies in sequence and arrangement of conserved motifs.
The H and P elements contain identical HD binding sites and a similar
arrangement of motifs.
Effects of adding the H element in the MOR23 minigene
Many OR promoters contain HD binding sites upstream of their
TSS suggesting a commonmechanism for gene regulation (Michaloski
et al., 2006; Hoppe et al., 2006). Site-directed mutagenesis of an HDotifs modulate the probability of odorant receptor gene choice in
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expression (Rothman et al., 2005). The exact conservation of the
13mer AACTTTTTAATGA encompassing a HD binding site in the P3
promoter and the P and H elements suggests that this site in particular
is involved in OR gene expression.
An alternative strategy to study the role of HD binding sites,
instead of deleting ormutating them, is to test whether the addition of
an intact HD binding site(s) affects the numbers of transgene-
expressing founders and lines, and the numbers of transgene-
expressing OSNs. We chose to test such effects on a minigene rather
than a promoter transgene, so that we could also evaluate axonal
coalescence into glomeruli, which is the strictest criterion to compare
expression patterns (Vassalli et al., 2002). In order to limit the effects
from intronic sequences, we used as basis for our transgenic strategy
the shortest OR minigene (TgΔ-MOR23) that recapitulates the
endogenous MOR23 expression pattern (Vassalli et al., 2002). This
transgene contains 405 bp upstream of the MOR23 TSS and an intact
MOR23 coding sequence, thereby enabling coalescence of axons into
the same glomeruli as axons of OSNs that express the endogenous
MOR23 locus (Vassalli et al., 2002). The difference with TgΔ-MOR23
(Vassalli et al., 2002) is that we now inserted IRES-tauGFP instead of
IRES-tauLacZ after the coding sequence (minigene TgΔ-MOR23-GFP).
Fluorescent cells are observed in the dorsal MOE, and labeled axons
converge to where MOR23 glomeruli are found normally (Fig. 6A).
In other studies, addition of the H element to a MOR28 minigene
resulted in a very high number of OSNs expressing the transgene
(Serizawa et al., 2003, 2006).We testedwhether a similar effect of theH
element is also observed on ourMOR23minigene. We inserted the full
2.1 kb H element upstream of TgΔ-MOR23-GFP, constructing transgene
Hf-TgΔ-MOR23-GFP (Fig. 5B). (‘f’ denotes the forward orientation of the
H element with regard to the MOR28 promoter in the endogenous
locus.) Most founders and lines show only modest increases in the
numbers of labeled cells in the MOE, and GFP-tagged axons coalesce
with MOR23-LacZ axons (Fig. 7 and data not shown). However, one
founder and one mouse line exhibit a very large number of transgene-
expressing OSNs in the dorsal region of the MOE (Figs. 6B, 7), with the
majority of axons coalescing into a large glomerulus, which is however
different from the endogenous MOR23 glomerulus (Fig. 6B).
Thus, in the particular conﬁguration that we tested, the H element
does not have the same dramatic and consistent effects on MOR23
minigene expression as onMOR28 (Serizawa et al., 2003). It is possible
that the H element has a stronger effect on a ventrally expressed OR
gene such as MOR28 than a dorsally expressed OR gene such as
MOR23. Alternatively, inhibitory sequences within the 2.1 kb H
element may mask the effect of stimulatory sequences on MOR23
minigene expression— a possibility that will be dealt with in the next
and ﬁnal series of constructs.
Effects on the MOR23 minigene of a multimerized 19mer containing an
intact HD binding site
We hypothesized that the exceptionally strong effect of the H and
P elements on gene expression could come from the triplet of TAATGA
HD binding sites (Fig. 5C) that are in common between the H element
(Fuss et al., 2007; Nishizumi et al., 2007; Serizawa et al., 2003) and the
P element (Bozza et al., 2009). In addition, TAATGA is a preferential
binding site for LHX2 (Berger et al., 2008). A direct test of the effect of
HD binding sites is to multimerize and insert them upstream of the
TgΔ-MOR23-GFP minigene. We chose the HD binding sequence
TAATGA within the extended 13 bp AACTTTTTAATGA, because this
sequence occurs as a perfect match in the P3 promoter and in both in
the H and P elements. We hypothesized that TAATGAmay work better
as a multimer (at least a triplet), but we were concerned that
concatenating the 13 bp may cause steric hindrance for HD protein
binding. Thus, we added additional nucleotides ac and agtc respec-
tively 5′ and 3′ to the HD site, giving rise to the 19mer sequence,Please cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11acAACTTTTTAATGAagtc (Fig. 5C). This 19mer is from the P element. Our
cloning strategy enabled us to concatenate this 19mer nine times (see
Experimental methods), and we refer to it as 9xHD.
Many of the 15 founders and mouse lines with the 9xHD-TgΔ-
MOR23-GFP transgene display a massive increase in the number of
labeled MOE cells in a dorsal region of the MOE (Figs. 6C, D, 7). Out of a
total of 24 founders and lines for 9xHD-TgΔ-MOR23-GFP or for this
transgene coinjected with a differentially marked transgene (see
below), all but one show expression of GFP (Fig. 7, summary; Fisher's
exact test p=0.004 compared to without 9xHD). The 9xHD sequence
does not generally alter the zonal speciﬁcity of the MOR23 minigene:
thedistribution in thedorsalMOE is preserved in all 9xHD-TgΔ-MOR23-
GFP and 9xmHD-TgΔ-MOR23-GFP founders and lines. Some lines show
an additional narrow ventral domain of expression (data not shown).
To explore whether a single OR transgene copy is expressed in the
9xHD transgenes in spite of the very high number of transgene-
expressing OSNs, we employed a second ﬂuorescent marker IRES-
taumRFP1 or IRES-taumCherry, constructing transgenes 9xHD-TgΔ-
MOR23-RFP and 9xHD-TgΔ-MOR23-Cherry respectively (Fig. 6D).
Coinjection of the GFP-marked minigene with the corresponding RFP-
or Cherry-marked minigenes also results in founders and lines with
high numbers of labeledMOE cells (Figs. 6D, 7). Importantly, nearly all
labeled cells exhibit red or green ﬂuorescence on a mutually exclusive
basis (Fig. 6D and inset; 9x19RFP8: n=345 red only, n=284 green
only, n=3 red+green), demonstrating that ~99% of transgene-
expressing OSNs express only one of the two types of transgenic
constructs (Serizawa et al., 2000). By crossing lines of the 9xHD-TgΔ-
MOR23 minigenes that have high numbers of labeled cells (lines
9x19-III, IV, VI; 9x19RFP8, 9; and 9x19Cherry13) to the corresponding
gene-targeted line MOR23-IRES-taulacZ, we conﬁrm that the two
types of labeled axons co-coalesce into the same glomeruli (Figs. 6F–
F’” and data not shown). Thus, theseminigenes are expressed in a very
similar way as the endogenous locus, but in many more OSNs.
Effects on the MOR23 minigene of a multimerized 19mer containing a
mutant HD binding site
To rule out that this 19mer sequence merely functions as an
insulator rendering the MOR23 promoter less sensitive to inhibitory
effects of ﬂanking genomic sequences at the transgene integration
sites, we introduced two A-to-G substitutions in the 19mer sequence
(mHD for mutant HD) that disrupt the HD core binding sequence:
ACAACTTTTTGGTGAAGTC. Importantly, founders and lines for the
9xmHD-TgΔ-MOR23-GFP minigene do not show the increased
numbers of labeled MOE cells that founders and lines with 9xHD
transgenes show (Figs. 6E and 7; Fisher's exact test p=0.028). None
of the 24 founders and lines show high numbers of labeled cells (N300
cells on turbinates), and ten exhibit no expression (Fig. 7; Fisher's
exact test for non-expressors p=0.017 compared to 9xHD). Axons
from the 9xmHD-TgΔ-MOR23-GFP-labeled cells also co-coalesce with
MOR23-LacZ labeled axons (Figs. 6G, G’).
Thus, the drastic effect of 9xHD on expression of a MOR23
minigene is only observed if the HD binding site is intact, strongly
implicating this site in OR gene choice.
Discussion
Promoter transgenes behave as ΔOR alleles
A series of studies have reported that OSNs that express either a
transgene (Serizawa et al., 2003) or a gene-targeted allele (Bozza
et al., 2009; Feinstein et al., 2004; Grosmaitre et al., 2009; Lewcock
and Reed, 2004; Shykind et al., 2004) that carries a deletion or
crippling mutation in the coding sequence of an OR, often coexpress
another endogenous OR locus with an intact and functional OR coding
sequence. The design of these knockout or deletion transgenes andotifs modulate the probability of odorant receptor gene choice in
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presumably chosen at random — before, around the same time, or
after ΔOR expression. The resulting phenotype is one of diffuse
projection of OSN axons to a broad subdomain of the olfactory bulb.
Each of these axons presumably innervates the glomerulus that is
appropriate for the OR that is coexpressed by the OSN from an
endogenous locus.
Apopular explanation for the co-expressionof a functionalOR locus in
ΔOR-expressing OSNs is the absence of some sort of negative feedback.
An OSN would be able to sense whether it expresses a functional OR
protein fromtheΔOR locus or transgene. In the absenceof a functionalOR
protein, the OSN would then sometimes proceed to a second attempt of
activating anORpromoter elsewhere in the genome (Fuss andRay, 2009;
Imai and Sakano, 2009). During normal differentiation inwild-typemice,
an OSN would sense a signal that emanates from the expression of a
functional OR protein, and not proceed to activate another OR locus. This
negative feedback is thought to contribute to the expression of one OR
gene per OSN. There are no candidates for proteins or mechanisms
underlying this negative feedback.
The phenotype of diffuse axonal projections for the promoter
transgenes described in this study is very similar to the previously
reported ΔOR phenotypes. Labeled axons do not coalesce into one or
few discrete glomeruli per bulb, instead they project diffusely to a broad
subdomain of the bulb. An extreme case is seenwith the Tg-P(122,195)-
LacZpA (also known as P-LacZ-Tg) mice, in which the P element drives
expression of tau-β-galactosidase in ~10% of OSNs, which project their
axons to a large majority of glomeruli in the bulb except for a dorsal
domain (Bozza et al., 2009).With these P-LacZ-Tgmice, we have shown
that on average ~9% of OSNs containing mRNA for a given class II OR
coexpress the P-LacZ-Tg, and ~0.09% (100× less frequently) for a given
class I OR (Bozza et al., 2009). Coexpression of endogenous OR loci with
our promoter transgenes remains to be characterized.Conserved motifs in OR promoter sequences
Our ORminigenes have helped to identify highly conserved motifs
near the TSS of several mouse OR genes (Vassalli et al., 2002; Rothman
et al., 2005). Other studies, which were not based on experimental
evidence of expression, also came up with the same conserved motifs
(Hoppe et al., 2006; Michaloski et al., 2006). Many of these motifs
appear to be HD and O/E binding sites. But these studies could not rule
out a role for other sequences in the minigenes, which contain
between 2.2 and 9 kb of genomic DNA. Furthermore, there is some
evidence for a role of the OR coding sequence itself in the regulation of
OR gene expression (Nguyen et al., 2007, 2010).Fig. 6. Increase in the number of OSNs expressing a MOR23 minigene by insertion of a 9xH
MOR23 coding sequence, and is similar in design to the TgΔ minigene described in Vassalli
inserted into a PacI site after the stop codon of the MOR23 coding sequence. Wholemount ﬂ
(left image), and coalescence of axons into a glomerulus with a position in the olfactory bulb
MOR23-GFP. One copy of the H element is inserted upstream of the TgΔ-MOR23-GFP mi
Wholemount ﬂuorescence from a transgenic founder (Hf-27) reveals greatly increased numb
large glomerulus, which is however not the endogenous MOR23 glomerulus, but more dorsal
glomerulus resides (arrow). (C) 9xHD-TgΔ-MOR23-GFP. A 19mer that is referred to as HD
contains a HD binding site, is concatenated 9 times (9xHD, represented with black triangle)
transgene contains theMOR23 coding sequence.Wholemount ﬂuorescence from a transgenic
(left image). In the bulb (right), labeled axons project to the endogenous MOR23 glomerul
9x19-III, IV, VI, data not shown). (D) 9xHD-TgΔ-MOR23-GFP minigene coinjected with eithe
MOR23 coding sequence.Wholemount ﬂuorescence from amouse of line RFP8 reveals red- or
axons co-coalesce into the endogenous MOR23 glomerulus (as conﬁrmed in crosses to MOR
labeled cells are rarely observed. (E) 9xmHD-TgΔ-MOR23-GFP. A mutant form of the 19me
TgΔ-MOR23-GFP minigene that is described in (A). The two A-to-G nucleotide substitution
transgene contains the MOR23 coding sequence. Wholemount ﬂuorescence from a mouse o
bulb, labeled axons coalesce into the endogenous MOR23 glomerulus (as conﬁrmed in cross
from a 9xHD-TgΔ-MOR23-GFP+9x HD-TgΔ-MOR23-RFP mouse of line RFP8 crossed to MOR
β-galactosidase, F) is also innervated by GFP-labeled axons (green, F’) and RFP-labeled axon
same glomerulus. (G, G’) Section through the bulb from a 9xmHD-TgΔ-MOR23-GFP mouse o
red with an antibody to β-galactosidase (G) and is coinnervated by GFP-labeled axons (G’)
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transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11Here, we have shown that mosaic, OSN-speciﬁc expression can be
conveyed by very small sequences from OR loci in promoter-taulacZ
transgenes that are devoid of an OR coding sequence: a mere ~300 bp
is sufﬁcient. Sequence comparisons between the mouse M71, mouse
M72 and hM72 minimal promoters reveals 49% identity (66/136 bp)
in the sequence upstream of the TSS. The homology between the P3
minimal promoter and the P element in the region upstream of the
TSS is 72% identity (86/119 bp). When these ﬁve sequences are
aligned, only three small stretches of homology are found within the
71–88 bp upstream of the TSS: one HD binding site, one O/E binding
site, and another motif AAACAG/CA just upstream of the TSS, near
where RNA polymerase II would be expected to bind.
Two lines of evidence fromour promoter transgenes further support a
role of the conserved HD and O/E binding sites in OR gene expression.
First, deletion of oneO/E binding site of theMOR23promoter, in promoter
transgene Tg-MOR23(148,40)-LacZpA, diminishes transgene expression
drastically. Second, ﬁve nucleotide substitutions in both the HD and O/E
sites in the M71 promoter, in promoter transgene Tg-M71(mHD+O/E
161, 176)-LacZpA, preclude transgene expression, revealing only a few
and faintly labeled OSNs. The identical mHD+O/E mutations introduced
in the M71 minigene with a similar upstream region (Rothman et al.,
2005) give rise to a few and faintly labeled OSNs as well.
We hypothesize that an assembly of factors at the HD and O/E
binding sites represents a crucial aspect of OR gene choice, in the
activation and/or themaintenance of transcription. The absence of class
II OR gene expression in mice mutant for the HD protein Lhx2 (Hirota
et al., 2007) argues for its involvement in class II OR gene choice and/or
maturation of OSNs that express class II OR genes. O/E proteins are four
transcription factors of the repeated helix–loop–helix (rHLH) type and
are highly expressed in the MOE. Physical coupling of bHLH and LIM-
homeodomain transcription factors on promoters has been proposed to
control the differentiation of motor neurons (Lee and Pfaff, 2003), and
could be used also for OR genes in OSNs.
Transgenic expression patterns
The promoter transgenes do not always reproduce accurately the
spatial expression patterns in the MOE. However, neither is the
expression of other OR transgenes in the literature perfect in all cases,
evenwithvery large transgenes suchas thosebased onyeast or bacterial
artiﬁcial chromosomes (Nakatani et al., 2003; Qasba and Reed, 1998;
Rothman et al., 2005; Serizawa et al., 2000; Vassalli et al., 2002; Zhang
et al., 2007). Speciﬁcally, theM72 and P3promoter transgenes tend tobe
expressed in a more ventral region of the MOE compared to their
endogenous counterparts. The M72 promoter sequence is shorter than
M71 and hM72 by 13/61 bp upstream of a conserved HD binding site.D multimer upstream. (A) TgΔ-MOR23-GFP. This MOR23 minigene (left) contains the
et al., 2002. Intron 2 is removed, and IRES (grey box) followed by tauGFP (green box)
uorescence from a transgenic founder (23DG-13) reveals dorsal expression in the MOE
that is similar to that of the endogenous MOR23 glomerulus (right image). (B) Hf-TgΔ-
nigene that is described in (A). This transgene contains the MOR23 coding sequence.
ers of labeled cells in the MOE (left image). Most of the labeled axons coalesce in a very
(right image). A minority of the labeled axons project to where the endogenous MOR23
(sequence in inset) and encompasses the conserved 13mer AACTTTTTAATGA, which
and inserted upstream of the TgΔ-MOR23-GFP minigene that is described in (A). This
founder (9x19-11) reveals greatly increased numbers of labeled cells in the dorsal MOE
us (as conﬁrmed in crosses to MOR23-IRES-tauLacZ with three lines of this construct:
r 9xHD-TgΔ-MOR23-RFP or 9xHD-TgΔ-MOR23-Cherry. All three transgenes contain the
green-ﬂuorescent cells in the dorsal MOE (left image). In the bulb (right), red and green
23-IRES-tauLacZ, see also (F’–F”)). Inset shows green- or red-ﬂuorescent cells; double-
r termed mHD (inset) is concatenated 9 times (9xmHD) and inserted upstream of the
s in mHD affect the conserved TAAT core sequence that is common to all HD sites. This
f line 11 reveals normal numbers of labeled cells in the dorsal MOE (left image). In the
es to MOR23-IRES-tauLacZ, see also (G) and (G’)). (F,F’,F”,F’”) Section through the bulb
23-IRES-tauLacZ (MOR23-LacZ). The endogenous MOR23 glomerulus (blue, antibody to
s (red, F”). The triple overlay in F’” shows convergence of the three types of axons to the
f line 11 crossed to MOR23-IRES-tauLacZ. The endogenous MOR23 glomerulus is labeled
. Glomeruli are surrounded by periglomerular cells (blue).
otifs modulate the probability of odorant receptor gene choice in
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Fig. 7. Cell counts for the various TgΔ-MOR23-GFP minigenes. (Top) The TgΔ-MOR23-GFP minigene consists of a 405 bp sequence upstream of the ﬁrst non-coding exon, then
nontranslated exons 1 and 2, followed by exon3 (containing theMOR23 coding sequence), and ﬁnally 1.7 kb of 3′ sequence. The intron between exon 1 and exon 2 has been removed. IRES
(grey box) followed by tauGFP (green box) is inserted into a PacI site after the stop codon of theMOR23 coding sequence (Vassalli et al., 2002). Variations of this minigene come in three
forms:+Hf,+9xHDor+9xmHD. Counts of labeled cells on olfactory turbinates (in groups of 10 s) are for transgenic founders (circles) or lines (squares). Cell counts ofmicederived from
coinjections of transgenes containing GFP and RFP, or GFP and Cherry, are also included for transgenic founders (red-ﬁlled circles with a green outline) and lines (red-ﬁlled squares with a
green outline). Black-ﬁlled squares or circles represent lines or founders with a low expression level per cell and in cells throughout the MOE, a likely consequence of genomic position
effects due to the integration site. One 9x19HD founder hadmosaic pan-neuronal expression combinedwith a dorsal pattern of expression,whichwas not included in theﬁgurebecause of
difﬁculty in counting.
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negative regulatory regions. The P3 promoter transgene contains 27 bp
fewer upstream of the HD binding site compared to theM71 promoter
family, andmay alsomiss some regulatory sequences. These ventralized
patterns are not only observed with minigenes and promoter
transgenes, but alsowith gene-targetedmutations in theM71 promoter
(Rothman et al., 2005). Our interpretation is that OR gene choice may
also be regulated by suppression or negative regulation in certain
regions of the MOE (Rothman et al., 2005); when these sequences are
missing or incomplete, ectopic expression can occur.
The 337 bp genomic sequence that we have termed the P element
(Bozza et al., 2009) was selected based on homology with the
experimentally validated P3 promoter sequence. We have no
evidence that the P element acts a promoter for an OR gene in the
cluster, but it can act as a promoter for tauLacZ in a transgenic context.
Unexpectedly this 337 bp sequence behaves very differently from the
other eight short promoters tested in this series of transgenic
constructs: up to 10% of OSNs express P-LacZ-Tg (Bozza et al.,
2009). The occurrence of HD and O/E binding sites in the P element is
consistent with their role in OR gene expression.
Further experiments
These promoter segments of ~300 bp can be reduced further and
dissected in our assay of promoter-tauLacZ transgenes. We retained
5′ nontranslated exon sequences in order to maintain stability of the
taulacZ mRNAs. For 55% of ~200 ORs analyzed, the endogenous
transcripts contain open reading frames of at least ten codons
upstream of the presumptive AUG start codon within 5′ nontrans-
lated exons (Michaloski et al., 2006). Whether these short, upstream
open reading frames have a regulatory function, can be tested by
deletion or by addition of heterologous or artiﬁcial 5′ nontranslated
exons. The most critical sequence could be the region encompassing
the HD and O/E binding sites. These two types of binding sites are
the only conserved motifs identiﬁed among ~200 putative OR
promoters (Michaloski et al., 2006). The third motif AAACAG/CA
located just upstream of the TSS is not conserved when many ORs
are examined.
H and P elements
The 2.1 kb H element was discovered by its high sequence
homology between human and mouse genomic sequence in the
MOR28 gene cluster (Serizawa et al., 2000, 2003). Its presence is
required for expression of three of seven adjacent OR genes including
MOR28 (Fuss et al., 2007), and a core region has been identiﬁed
(Nishizumi et al., 2007). When the H element is placed 5 kb upstream
of the TSS in an otherwise non-functionalMOR28minigene, transgene
expression is not only restored, but the numbers of expressing OSNs
are extremely high (Serizawa et al., 2003). It appears that the
relocation of the H element ~50 kb closer to theMOR28 TSS increases
the probability of expression. Similarly, our P-LacZ-Tg promoter
transgene is expressed in ~10% of OSNs. We suggest that the H and P
elements have evolved high-afﬁnity binding sites, enabling them to
operate on OR promoters from their remote locations. Evolution of
strong, long-distance regulatory elements within and nearby OR gene
clusters would favor the maintenance of OR function.
A comparison of the sequence of the mouse H and P elements
reveals a set of three HD binding sites in close proximity to each other,
and an associated O/E site. The three TAATGA HD binding sites in the P
element are within a 45 bp stretch of DNA, or 75 bp if the O/E site is
included. The TAATGA HD binding sites of the H element are within
92 bp of each other, and within 125 bp of the ﬁrst O/E site. A 13 bp
perfect match between the two elements includes one of the HD
binding sites. This sequence alone cannot explain the strength of the
activity of the P element in P-LacZ-Tg, because it is also conserved inPlease cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11the P3 promoter, which is expressed in much fewer cells (Feinstein
and Mombaerts, 2004). Interestingly, the P3 promoter contains only
one additional TAATGA HD site, but the P and H elements contain two
such additional sites.
We tested the notion of tightly linked HD binding sites cooperating
to achieve high numbers of expressing OSNs by multimerizing a
19mer from the P element. The MOR23 coding sequence was included
in these transgenic constructs in order to evaluate patterns of axonal
coalescence. The numbers of expressing transgenic lines and of
expressing OSNs are increased dramatically with the 9xHD constructs.
Despite the elevated numbers of transgene-expressing OSNs, the
transgene appears to expressed from a single copy in most cells. The
involvement of a functional HD binding site in this effect is strongly
suggested by the absence of such a boost with the mutant 9xmHD
constructs. Axons of OSNs expressing MOR23 from the 9xHD
transgene co-converge into the same glomeruli as axons of OSNs
expressing MOR23 from the endogenous locus, suggesting that the
level of MOR23 expression per OSN is normal.
We hypothesize that this multimerized 9xHD sequence increases
the probability of transgenic OR gene expression by enabling strong
cooperative interactions among HD binding proteins. Similarly, the
triplets of TAATGA HD binding sites in the H and P elements together
would constitute an exceptionally high-afﬁnity binding site for HD
binding proteins. This assembly of HD binding proteins and perhaps
other factors would then serve as a binary on-off switch for adjacent
OR genes in the cluster: the ‘choice’ of one OR gene for high-level
transcription. Likewise, we hypothesize that HD binding sites within
OR promoters themselves modulate the probability of OR gene choice.
Mechanistically, HD binding motifs could modulate the probability of
OR gene choice by attracting polymerase assembly factors, enhancing
transcription initiation, or stabilizing transcription elongation.
Conclusion
The total number of OSNs that express a given OR in amouse varies
over two orders of magnitude (Mombaerts, 2004). We speculate that
this number may be critically determined by the number and the
strength of the HD binding sites in regulatory elements such as H and
P elements, by the number and strength of the HD binding sites in OR
promoters, and by the distance between these regulatory elements
and OR promoters.
Experimental methods
Promoter transgenes
The PacI–EcoRI–IRES–NcoI–tauLacZ–XbaI fragment (Mombaerts
et al., 1996) was ligated with a 556 nt XbaI-rabbit globin pA–EcoRV–
PacI–XbaI fragment, thereby generating the PacI cassette IRES–
tauLacZpA. Next, the EcoRI–IRES–NcoI fragment was replaced with OR
(X,Y) promoter segments of the type EcoRI–EcoRV–OR (X,Y)–Kozak–
NcoI thatwere generated by PCR, resulting in transgenes ﬂanked by PacI
restriction sites: OR (X,Y)–tauLacZpA. (X,Y) indicate the bp position
upstream and downstream, respectively, of the TSS as deﬁned by 5′
RACE. The NcoI site contains the start codon ATG for methionine. The
nucleotides GCCA were inserted upstream of the NcoI site (CCATGG) to
mimic a Kozak sequence, insuring more efﬁcient translation of the β-
galactosidase protein. The mouse promoter fragments are from the 129
genetic background. The hM72 (154,146) fragment is from BAC 210L3
(Genome Systems). All promoter fragments were sequenced. These
plasmids are publicly available from Addgene (Cambridge, MA, USA).
MOR23 minigenes
The TgΔ-MOR23minigene is a SacI–NheI fragment, but with intron
2 fused with intron 3 (Vassalli et al., 2002). A PacI site is located 3otifs modulate the probability of odorant receptor gene choice in
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tauGFP (-GFP) was inserted generating TgΔ-MOR23-GFP. The H
element was ampliﬁed by PCR from 129 mouse genomic DNA origin
including 5′ and 3′ SacI restriction sites and cloned into the SacI site of
the TgΔ-MOR23-GFP minigene generating Hf-TgΔ-MOR23-GFP. The
identiﬁed conserved sequences in the H element are identical in the
C57BL/6J strain.
The transgenes 9xHD-TgΔ-MOR23-GFP and 9xmHD-TgΔ-MOR23-
GFP were constructed as follows. A pair of unphosphorylated oligos
containing three times the HD-containing sequence ACAACTTTTTAAT-
GAAGTC or three times the mutant sequence ACAACTTTTTGGTGAAGTC
from 129 mouse genomic DNA origin were annealed and ligated into
the SacI digested TgΔ-MOR23-GFPminigene. Themutation (AA to GG)
abolishes the A2A3 core of the T1A2A3T4HD recognition site; other pairs
of AA nucleotides are retained in the oligos. Clones were screened for a
triplet insertion in the same orientation (same as HD site 2 in the P
element, Fig. 5C) and sequenced. Oligos:
3xHD-1:
CACAACTTTTTAATGAAGTCACAACTTTTTAATGAAGTCACAACTTTTTAATG-
AAGTCGAGCT
3xHD-2:
CGACTTCATTAAAAAGTTGTGACTTCATTAAAAAGTTGTGACTTCATTAAA-
AAGTTGTGAGCT
3xmHD-1:
CACAACTTTTTGGTGAAGTCACAACTTTTTGGTGAAGTCACAACTTTTTGGTG-
AAGTCGAGCT
3xmHD-2:
CGACTTCACCAAAAAGTTGTGACTTCACCAAAAAGTTGTGACTTCACCAAAA-
AGTTGTGAGCT
PacI cassettes containing IRES-taumRFP1 or IRES-taumCherry
were ligated into the 9xHD-TgΔ-MOR23 minigene.
Transgenic mice
Plasmid inserts were released for pronuclear microinjection into
F2 (C57BL/6J×CBA) zygotes, with PacI for the promoter transgenes
and with PmeI–NheI for the MOR23 minigenes. Founders included in
the analysis are distinct from founders bred with C57BL/6J mice to
transmit the transgene through the germline and establish lines. For
each transgenic construct that gives expression, one representative
line has been cryopreserved as sperm at The Jackson Laboratory (Bar
Harbor, Maine, USA), and is publicly available.
Sequences of promoter transgenes
For unambiguous identiﬁcation of the genomic segments from OR
loci that are included in the promoter transgenes, below are the
sequences of the variable, relevant parts. Under the name of the
transgene is theAddgeneNumber ID for the plasmid. Sequences that are
underlined represent a PacI restriction site; italics, EcoRI restriction site;
underlined italics, EcoRV restriction site; forward slashes, boundary
between restriction sites and promoter sequence; capitals underlined,
Kozak sequence; capitals italics, NcoI restriction site encompassing ATG
start codon. The length of the sequence between the forward slashes
corresponds to the sum of the numbers x and y. Under each sequence is
listed our line number, the JR number assigned by The Jackson
Laboratory, and the ofﬁcial name of the line in a mixed C57BL/6×CBA
background that is publicly available from The Jackson Laboratory.
Tg-M71(161,176)-LacZpA
Addgene 15605
ttaattaagaattcgatatc/gaagaattaacacacttgggaaataaaacatgattcacagaa-
caagagaaaacatgaactaattgttactttagagacaacaatggtctctagagtgacta-Please cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11tatcccaggagatgatccacacacacacacacatatatataaacagaacccccaatttttagt-
catattatatcacctttccaaatgacaatctccttttccggactagactgggctctttaag-
taaattttgtggtgtatacacatctgcatacttctagaatttactgaatattgaagccacaga-
cattgcctgaagtttcatttgagacgctgtttcatttccttcagcacag/GCCACCATGG
line IV, JR#7972, B6;CBA-Tg(Olfr151-tauLacZ)4Mom/MomJ
Tg-M71(161mHD+O/E,176)-LacZpA
Addgene 15606
ttaattaagaattcgatatc/gaagaattaacacacttgggaaataaaacatgattcacagaa-
caagagaaaacatgaactggttgttactttagagacaacaatggtctctagagtgactata-
taggaggagatgatccacacacacacacacatatatataaacagaacccccaatttttagt-
catattatatcacctttccaaatgacaatctccttttccggactagactgggctctttaag-
taaattttgtggtgtatacacatctgcatacttctagaatttactgaatattgaagccacaga-
cattgcctgaagtttcatttgagacgctgtttcatttccttcagcacag/GCCACCATGG
Tg-MOR23(148,154)-LacZpA
Addgene 15603
ttaattaagaattcgatatc/aactgatgcacaacatcttcagaaacttctgaaggaagggaa-
gaaagaaacacctgggaagcagcctctggggaatcccaaaatgtcaccccctgagataag-
taaaaacccctgtttttaataaaatcccctggtatctatttgtgacacgacttttctggttcccct-
gagataccaagggagctgtgaagaaaggagagccaggtgggtgtggtaga-
cagtgttgtttcctttggagatttctcttgatctctgaaaccacagaggcttcttctcctattag-
caccactttcagagcctgg/GCCACCATGG
line I, JR#7973, B6;CBA-Tg(Olfr16-tauLacZ)1Mom/MomJ
Tg-MOR23(148,40)-LacZpA
Addgene 15604
ttaattaagaattcgatatc/aactgatgcacaacatcttcagaaacttctgaaggaagggaa-
gaaagaaacacctgggaagcagcctctggggaatcccaaaatgtcaccccctgagataag-
taaaaacccctgtttttaataaaatcccctggtatctatttgtgacacgacttttctggttcccct-
gagataccaagggagctgtg/GCCACCATGG
Tg-M72(135,163)-LacZpA
Addgene 15607
ttaattaagaattcgatatc/cagaaattagcacatataggactgaggagtacatacaagc-
caagactaattgtttctttagagaggacccagtccccatgtgactcctcccagga-
gatgttcggtatatatctatgtaaacagaacgcttgctccactatcatgatgattcctttttct-
taacagtgccaggcccttgcagtaaatttagcactagatataaatccatttatattatctgtttt-
cagcatctgctaattgttgagaccaaaggcatcccttaaagtttccagaggctcat-
cacttcccttccacaaag/GCCACCATGG
line V4-7, JR#7974, B6;CBA-Tg(Olfr160-tauLacZ)V4-7Mom/MomJ
Tg-hM72(154,146)-LacZpA
Addgene 15608
ttaattaagaattcgatatc/aggaaaattaacacacctgggagacaaagcatgtttctca-
gagccagtgtaaagcaaggctctaattgctctgttagtgagaaccccagcctctcaagtgat-
tatagcccaggaaatattgtgcccacatattcgtaaacacaatcccaagcccccagtcttagt-
gatccattttttaatgaatttgagtaaatgtaggactcagtataaatcagtatggttcctg-
cattttctgattgttgaaaccaaggcagcccttaaagtttccagcagactgtgctt-
tatttttcctcatcacag/ GCCACCATGG
line I, JR#7975, B6;CBA-Tg(OR8A1-tauLacZ)1Mom/MomJ
Tg-hM72(110,29)-LacZpA
Addgene 15609
ttaattaagaattcgatatc/cagtgtaaagcaaggctctaattgctctgttagtgagaaccc-
cagcctctcaagtgattatagcccaggaaatattgtgcccacatattcgtaaacacaatcc-
caagcccccagtcttagtgatccattttttaatgaa/GCCACCATGG
Tg-P3(143,163)-LacZpA
Addgene 15610otifs modulate the probability of odorant receptor gene choice in
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15A. Vassalli et al. / Molecular and Cellular Neuroscience xxx (2010) xxx–xxxttaattaagaattcgatatc/tatctagcatcagagtgactcattaacaactttttaatgagga-
cacagtaactgtccattagtacatcatttagactgaagccccagagaaaactgagta-
caaaaatcaatgacaacagagttcagaccacaagcagcatatcggagtgaagagagtg-
gactttctcagcagaagccaccaggcttttactgttgagtctccagggtctttgcaggtcc-
cagtggctatgattctggatataaaaatagagggaccaggggctttgtgggaggaaagga-
caactgagcagagtgatctgagacctg/GCCACCATGG
line IV, JR#7976, B6;CBA-Tg(Olfr713-tauLacZ)4Mom/MomJ
Tg-P(122,195)-LacZpA (referred to as P-LacZ-Tg in Bozza et al., 2009)
Addgene 15611
ttaattaagaattcgatatc/tccctgtgcagcagagtagctcattaacaactttttaatgaagt-
cacagatagtgactgctcattaataaatttattagtctgcagccccagagattaaagaaact-
gaaaacagaagtcagtgacaacagtgtttagccagagtagctgcatcagagtgaaaa-
gaGggaacttctcttggcagactctgaaacttttactgttggacctctagggtccttg-
caggtcccagaaactgtaattctgaaaatagaaacctggggggactaagaacttgatgg-
gatgaaggaaaaacagagccaaatgatcccaggcttg/GCCACCATGG
line 8, JR#6742, Tg(P-taulacZ)8Mom/MomJ
line 11, JR#6743, Tg(P-taulacZ)11Mom/MomJ
line 13, JR#6793, Tg(P-taulacZ)13Mom/MomJ
IDs of MOR23 minigenes and transgenic lines
TgΔ-MOR23-GFP
Addgene 15612
Hf-TgΔ-MOR23-GFP
Addgene 15613
line Hf#7, JR#7977, B6;CBA-Tg(Hf/Olfr16-tauGFP)7Mom/MomJ
line Hf#47, JR#7978, B6;CBA-Tg(Hf/Olfr16-tauGFP)47Mom/MomJ
9xHD-TgΔ-MOR23-IRES-GFP
Addgene 15614
line III, JR#7979, B6;CBA-Tg(H/Olfr16-tauGFP)3Mom/MomJ
line IV, JR#7980, B6;CBA-Tg(H/Olfr16-tauGFP)4Mom/MomJ
line VI, JR#7981, B6;CBA-Tg(H/Olfr16-tauGFP)6Mom/MomJ
9xHD-TgΔ-MOR23-IRES-taumRFP plus p9xHD-TgΔ-MOR23-IRES-
GFP
Addgene 15615 for 9xHD-TgΔ-MOR23-IRES-taumRFP
line RFP8, JR#7982, B6;CBA-Tg(H/Olfr16-taumRFP,H/Olfr16-
tauGFP)8Mom/MomJ
line RFP9, JR#7983, B6;CBA-Tg(H/Olfr16-taumRFP,H/Olfr16-
tauGFP)9Mom/MomJ
9xHD-TgΔ-MOR23-IRES-taumCherry plus p9xHD-TgΔ-MOR23-
IRES-GFP
Addgene 15616 for 9xHD-TgΔ-MOR23-IRES-taumCherry
line Cherry#11, JR#7984, B6;CBA-Tg(H/Olfr16-taumCherry,H/
Olfr16-tauGFP)11Mom/MomJ
line Cherry#13, JR#7985, B6;CBA-Tg(H/Olfr16-taumCherry,H/
Olfr16-tauGFP)13Mom/MomJ
9xmHD-TgΔMOR23-IRES-tauGFP
Addgene 15167
line 11, JR#7986, B6;CBA-Tg(H*/Olfr16-tauGFP)11Mom/MomJ
line 25, JR#7987, B6;CBA-Tg(H*/Olfr16-tauGFP)25Mom/MomJ
5′RACE
RNA was prepared from mice between postnatal day 15–28 using
the Qiagen RNeasy Kit. Reverse transcription was carried out with thePlease cite this article as: Vassalli, A., et al., Homeodomain binding m
transgenic mice, Mol. Cell. Neurosci. (2010), doi:10.1016/j.mcn.2010.11SMART RACE cDNA ampliﬁcation Kit (Clontech/Takara cat. no. 63914).
Oligos used for 5′RACE of the P4 gene are as follows: 1573 (5′
CAGAATGACTAGGTTGAAGCCGATCTCCAT 3′), CAT135 (5′ CCCAGCAGAG-
TAACCAGGTAGATGGTGAG 3′), and CAT136 (5′ GCTTGTGTCCTGGGCAAT-
CAGAGTCCTC 3′). Transgene 5′RACE analysis was with an internal LacZ
oligo.
Analysis of LacZ expression
Blue precipitate for wholemount analysis was obtained with X-gal
(Mombaerts et al., 1996). Mice for cryosectioning were drop-ﬁxed for
~3 h in PLP (2% formaldehyde, 13.5 mg/ml lysine, 2.1 mg/ml sodium
periodate, and 0.1 M sodium phosphate buffer at pH 7.4). Immuno-
histochemistry was with rabbit anti-β-galatosidase antibody (Cappel)
at 1:1000 dilution, followed by Red-X-conjugated or Cy5-conjugated
goat afﬁnity puriﬁed antibodies to rabbit IgG (Jackson ImmunoR-
esearch) at 1:200 dilution. Fluorescent sections were analyzed with a
Zeiss LSM 510 confocal microscope.
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